Latest News about SUPN
Recent news which mentions SUPN
Screening For Black Friday Bargains In The Stock Market
December 03, 2024
From Benzinga
ADHD Drug Maker Supernus Pharmaceuticals Downgraded On Slower Prescription Growth For Its Top-Selling Drug
September 11, 2024
From Benzinga
This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
September 11, 2024
From Benzinga
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
September 11, 2024
From Benzinga
From InvestorPlace
Tickers
SUPN
From InvestorPlace
Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson's Disease
April 08, 2024
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 08, 2024
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
December 14, 2023
From InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
From Benzinga
Earnings Scheduled For November 8, 2023
November 08, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
From Benzinga
Tickers
SUPN
From Motley Fool
Earnings Scheduled For May 9, 2023
May 09, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
FDA Rejects Supernus Pharma's Minimally Invasive Parkinson's Therapy
October 10, 2022
Tickers
SUPN
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.